Lv7
4960 积分 2022-08-15 加入
Ten-year overall survival in resectable stage-III NSCLC - Results of the randomized ESPATUE trial – Long-term survival and competing risk analysis
20天前
已完结
What is the optimal threshold for aberrant lymphoblasts at diagnosis to predict lymphoid transformation in chronic myeloid leukemia?
21天前
已完结
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
29天前
已完结
Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: Olverembatinib
1个月前
已完结
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world study
1个月前
已完结
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)
1个月前
已完结
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML
1个月前
已完结
Maintenance Therapy in Acute Myeloid Leukemia
1个月前
已完结
FLT3 mutations as diagnostic and prognostic biomarkers in acute myeloid leukemia
1个月前
已完结
The global epidemiology of acute myeloid leukaemia
2个月前
已完结
皖公网安备34019202002308
